Researcher
Isabel Leroux-Roels
- Keywords:vaccine immunology, infection prevention, infection control, vaccinology
- Disciplines:Diagnostics, Medicinal products, Laboratory medicine, Bacteriology, Infectious diseases, Vaccinology, Virology
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Nov 2003 → 30 Sep 2018
Projects
1 - 2 of 2
- HIGH-THROUGHPUT, HIGH-SENSITIVITY AND COST-EFFECTIVE MONITORING OF INNATE AND ADAPTIVE IMMUNE RESPONSES AT SINGLE CELL LEVELFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Rapid ex-vivo detection, quantification and characterisation of cell-mediated immune responses induced by natural infection or vaccination with SARS-CoV-2 orr other pathogens.From1 Apr 2021 → 31 Mar 2023Funding: IOF - technology validation in lab
Publications
1 - 10 of 45
- Sanitary installations and wastewater plumbing as reservoir for the long-term circulation and transmission of carbapenemase producing Citrobacter freundii clones in a hospital setting(2023)
Authors: Hannelore Hamerlinck, Annelies Aerssens, Jerina Boelens, Anne-Sophie Messiaen, Stien Vandendriessche, Anja Velghe, Isabel Leroux-Roels, Bruno Verhasselt
- Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine(2023)
Authors: Isabel Leroux-Roels, Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Cathy Maes, Paul-Henri Lambert, Geert Leroux-Roels
- Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults : phase 1/2 randomized clinical trial(2023)
Authors: Isabel Leroux-Roels, Matthew G Davis, Katie Steenackers, Brandon Essink, Corinne Vandermeulen, Charles Fogarty, Charles P Andrews, Edward Kerwin, Marie Pierre David, Laurence Fissette, et al.
Pages: 761 - 772 - Selective digestive decontamination-Pro(2023)
Authors: Jan De Waele, Isabel Leroux-Roels, Pieter Depuydt
Pages: 979 - 981 - Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin(2023)
Authors: Elien Vandoorn, Wojciech Stadejek, Isabel Leroux-Roels, Geert Leroux-Roels, Anna Parys, Kristien Van Reeth
Pages: 98 - 109 - Respiratory syncytial virus prefusion F protein vaccine in older adults(2023)
Authors: Alberto Papi, Michael G. Ison, Joanne M. Langley, Dong-Gun Lee, Isabel Leroux-Roels, Federico Martinon-Torres, Tino F. Schwarz, Richard N. van Zyl-Smit, Laura Campora, Nancy Dezutter, et al.
Pages: 595 - 608 - Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial(2022)
Authors: Karin Hardt, An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, et al.
Pages: 1703 - 1715 - Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine(2022)
Authors: Isabel Leroux-Roels, Gwenn Waerlop, Jessika Tourneur, FIEN DE BOEVER, Catherine Maes, Jacques Bruhwyler, Delphine Guyon-Gellin, Philippe Moris, Judith Del Campo, Paul Willems, et al.
- Practice testing of generic quality indicators for responsible antibiotic use in nine hospitals in the Dutch–Belgian border area(2022)
Authors: A.A. Monnier, I. Willemsen, M.F.Q. Kluytmans-van den Bergh, J.A.J.W. Kluytmans, A. Schuermans, Isabel Leroux-Roels, I.C. Gyssens
Pages: 153 - 161 - Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD) : a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial(2022)
Authors: Peter G. Kremsner, Rodolfo Andres Ahuad Guerrero, Eunate Arana-Arri, Gustavo Jose Aroca Martinez, Marc Bonten, Reynaldo Chandler, Gonzalo Corral, Eddie Jan Louis De Block, Lucie Ecker, Julian Justin Gabor, et al.
Pages: 329 - 340